The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Symptomatic children may have pulmonary embolism and/or deep vein thrombosis at similar rates to adults, despite current literature.

Suppressing REM sleep with antidepressants may increase survival in patients with amyotrophic lateral sclerosis.

The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in ...

Measles is highly contagious among those who are unvaccinated and may have severe health consequences in children under age 5 ...

In acute respiratory distress syndrome (ARDS), inflammatory phenotypes can be classified at the bedside in real time in a ...

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

A brief nurse-led intervention had a greater effect on dyspnea among patients who experience improvement in their psychological distress.

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

House Republicans' proposed $880 billion reduction in Medicaid funding is expected to leave millions uninsured and lead to hospital closures.